Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH207641FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (FDZJ), a subsidiary of Shanghai Pharmaceutical Co Ltd, is a bio-pharmaceutical company that develops, manufactures and markets genetic engineering drugs. The company offers bio-pharmaceutical products in the field of genetic engineering, photodynamic therapy and nano-drugs. Its products comprise aminolevulinic acid hydrochloride, hemoporfin for Injection and liposomal drugs include doxorubicin liposome among others. FDZJ also offers medical diagnostic products such as Down’s syndrome screening diagnostic reagent. It offers photodynamic therapy drug products such as aminolevulinic acid hydrochloride and hemoporfin for injection, among others. The company markets its products across China. FDZJ is headquartered in Shanghai, China

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Key Recent Developments

Apr 09,2021: Fudan Zhangjiang 2020 annual performance briefing meeting successfully concluded 2021-04-08
Mar 31,2021: Shanghai FudanZhangjiang Bio-Pharmaceutical announces Annual Results for the Year Ended 31 December 2020

This comprehensive SWOT profile of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Information
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Overview
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Employees
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Employee Biographies
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Operational Heads
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Major Products and Services
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – History
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Company Statement
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Locations And Subsidiaries
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Business Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Corporate Strategy
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Strengths
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Weaknesses
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Opportunities
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Threats
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Information
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Ratios
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Share Data
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Major Products and Services
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, History
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Employees
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Employee Biographies
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Operational Heads
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Other Locations
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Subsidiaries
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Competitors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, SWOT Analysis
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Ratios based on current share price
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Annual Ratios
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IDBI Bank Ltd:戦略・SWOT・企業財務分析
    IDBI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IDBI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • AGA Rangemaster Group Ltd:企業の戦略的SWOT分析
    AGA Rangemaster Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Isagen SA ESP:電力:M&Aディール及び事業提携情報
    Summary Isagen SA ESP (Isagen), a subsidiary of BRE Colombia Hydro Investments Limited, is an electricity utility that generates and markets electricity. It also supplies natural gas; and sells coal, steam, and other energy sources. The company produces electric energy from hydro and natural gas sou …
  • Ittehad Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Ittehad Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Flex Ltd (FLEX):企業の財務・戦略的SWOT分析
    Flex Ltd (FLEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Kedrion SpA-製薬・医療分野:企業M&A・提携分析
    Summary Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products …
  • Cafe De Coral Holdings Limited
    Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bukwang Pharm Co Ltd (003000)-製薬・医療分野:企業M&A・提携分析
    Summary Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company which develops pharmaceutical products and new drugs. The company’s product portfolio includes levovir, legalon, dexid, thioctacid, lonasen, ixel, Orfil, azeptin, asima among others. Its pipeline products comprise MLR-1023, JM-010, JM …
  • Empresas Publicas De Medellin ESP:電力:M&Aディール及び事業提携情報
    Summary Empresas Publicas De Medellin ESP (EPM) is a decentralized body, operational under the ownership of Medellin municipality. It generates, transmits, and distributes electricity as well as undertakes gas distribution, wastewater and garbage treatment, and telecommunications services across the …
  • UroGen Pharma Ltd (URGN)-製薬・医療分野:企業M&A・提携分析
    Summary UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd is a biopharmaceutical company that develops uro-oncology drugs and urological pathologies. The company’s pipeline products comprise drug candidates for various forms of non-muscle invasive urothelial cancer, including low grade bladd …
  • Logistec Corp (LGT.B):企業の財務・戦略的SWOT分析
    Summary Logistec Corp (Logistec) is a marine cargo handling company that provides services to marine and environmental sectors. The company offers services such as stevedoring, warehousing and distribution, stuffing and destuffing of containers, dockage, transportation, and passenger services. Logis …
  • Qurient Co Ltd (115180):製薬・医療:M&Aディール及び事業提携情報
    Summary Qurient Co Ltd (Qurient) is a pharmaceutical company that offers development of new drugs for unmet medical needs. The company provides portfolio of pipeline products such as Q301, Q203, Q701, 5LO INH and CDK7 INH, among others. It is developing products for the treatment of atopic dermatiti …
  • NantKwest Inc (NK):製薬・医療:M&Aディール及び事業提携情報
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • Teledyne Technologies Incorporated:企業の戦略・SWOT・財務情報
    Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • RH Petrogas Ltd (T13):石油・ガス:M&Aディール及び事業提携情報
    Summary RH Petrogas Ltd (RH Petrogas) is an oil and gas company that explores, develops and produces oil and gas resources. The company’s properties include FUYU 1 block, Basin and Island PSC, and SK331 PSC. Its FUYU 1 block property is located in south-east of the Fuyu oilfield in the Jilin provinc …
  • Comrod Communication ASA:企業の戦略・SWOT・財務情報
    Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report Summary Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Unit Corp (UNT):企業の財務・戦略的SWOT分析
    Summary Unit Corp (Unit) is a diversified energy company that offers exploration and production of oil and natural gas. The company offers acquisition of producing oil and natural gas properties, contract drilling of onshore oil and natural gas wells, and gathering and processing of natural gas. It …
  • Cofidis Participations S.A.:企業の戦略・SWOT・財務分析
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hogan Lovells International LLP:企業の戦略的SWOT分析
    Hogan Lovells International LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆